Profile
BDXA MDLN ISRG BDX ALC RMD
Company Name Becton, Dickinson and Company Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $55.91B $507.11B $198.93B $55.24B $39.08B $36.04B
Employees 0.00K 43.00K 15.64K 70.00K 25.60K 9.98K
CEO - James Boyle David J. Rosa Thomas E. Polen Jr. David J. Endicott Michael J. Farrell
Ratings
BDXA MDLN ISRG BDX ALC RMD
Quant Rating Score 5 3 3 3 3
Quant Rating Strong Buy Neutral Neutral Neutral Neutral
Trading
BDXA MDLN ISRG BDX ALC RMD
Last Close $59.24 - $546.71 $190.98 $76.61 $244.71
High 52 $59.24 - $610.45 $249.08 $98.3 $293.73
Low 52 $59.24 - $429.59 $165.15 $72.05 $204.58
Price vs. 52 Week High 0 % - -10.44 % -23.33 % -22.07 % -16.69 %
Price vs. 52 Week Low 0 % - 27.26 % 15.64 % 6.33 % 19.62 %
Total Return
BDXA MDLN ISRG BDX ALC RMD
1 Month Return 0 % - 22.54 % 0.99 % 2 % -8.72 %
3 Month Return 0 % - 13.64 % -2.06 % -13.07 % -14.47 %
6 Month Return 0 % - -3 % 8.88 % -14.72 % -2.77 %
9 Month Return 0 % - -9.02 % -15.17 % -14.35 % 6.13 %
YTD Return 0 % - 4.74 % -15.82 % -9.75 % 7.01 %
1 Year Return 0 % - 1.46 % -14.22 % -10.32 % 2.77 %
3 Year Return 0 % - 0 % 0 % 0 % 0 %
5 Year Return 0 % - 0 % 0 % 0 % 0 %
Dividends
BDXA MDLN ISRG BDX ALC RMD
Dividend Yield Percentage (TTM) 2.08 % - - 2.16 % 0.42 % 0.92 %
Dividend Paid and Capex Coverage Ration (TTM) 1.75 % - 4.3 % 1.75 % 3.26 % 4.31 %
Dividend Per Share (TTM) 4.17 % - - 4.16 % 0.33 % 2.26 %
Payout Ratio (TTM) 71.28 % - - 71.28 % 15.71 % 22.31 %
Growth
BDXA MDLN ISRG BDX ALC RMD
Asset Growth -3.42 % -3.42 % 2.48 % 18.95 %
Gross Profit Growth 8.76 % 8.76 % 5.05 % 15.05 %
Revenue Growth 8.23 % 8.23 % 4.82 % 9.84 %
Revenue 3 Year 15.09 % 15.09 % 18.48 % 43.19 %
Revenue 5 Year 32.24 % 32.24 % 30.35 % 71.22 %
Revenue 10 Year 50.09 % 50.09 % 50.3 % 193.47 %
EBIT Growth -1.5 % -1.5 % 41.82 % 28.01 %
Net Income Growth -1.58 % -1.58 % 4.52 % 37.2 %
Net Income 3 Yeari Growth Per Share -6.21 % -6.21 % 168.34 % 78.91 %
Net Income 5 Yeari Growth Per Share 86.87 % 86.87 % 253.24 % 121.66 %
Net Income 10 Yeari Growth Per Share 70.61 % 70.61 % 239.64 % 280.03 %
Operating Income Growth 7.55 % 7.55 % 36 % 27.69 %
Operating Cash Flow Growth (CFG) -9.69 % -9.69 % 49.64 % 25 %
Operating 3 Year CFG 29.54 % 29.54 % 53.05 % 396.61 %
Operating 5 Year CFG -5.66 % -5.66 % 122.93 % 114.79 %
Operating 10 Year CFG 40.19 % 40.19 % 55.79 % 337.65 %
EPS Growth -0.68 % -0.68 % 4.04 % 37.61 %
EPS Diluted Growth -0.51 % -0.51 % 4.59 % 37.43 %
Book Value Per Share -0.85 % -0.85 % 4.21 % 22.95 %
Share Holder 3 Year Equity Growth Per Share -0.14 % -0.14 % 10.93 % 76.79 %
Share Holder 5 Year Equity Growth Per Share 3.99 % 3.99 % 10.26 % 135.12 %
Share Holder 10 Year Equity Growth Per Share 150.41 % 150.41 % -9.87 % 259.96 %
Dividend Per Share Growth 9.92 % 9.92 % 11.75 % 10.35 %
Dividend 3 Year Growth Per Share 9.92 % 9.92 % 138.09 % 26.15 %
Dividend 5 Year Growth Per Share 13.46 % 13.46 % - 35.87 %
Dividend 10 Year Growth Per Share 74.26 % 74.26 % - 89.26 %
Debt Growth -4.62 % -4.62 % 0.02 % -2.53 %
Free Cash Flow Growth -13.09 % -13.09 % 162.01 % 29.18 %
Updated On 30 Sep 2025 30 Sep 2025 31 Dec 2024 30 Jun 2025
Profitability
BDXA MDLN ISRG BDX ALC RMD
Gross Profit Margin TTM 45.44 % 66.41 % 45.44 % 55.13 % 60.08 %
Return on Assets TTM 3.03 % 14.19 % 3.03 % 3.42 % 17.31 %
Return on Equity TTM 6.63 % 16.08 % 6.63 % 4.93 % 25.13 %
Return on Capital Employed TTM 5.48 % 16.05 % 5.48 % 4.98 % 24.74 %
Net Income Per EBT TTM 89.16 % 86.77 % 89.16 % 85.57 % 82.6 %
EBT Per Ebit TTM 73 % 112.41 % 73 % 86.96 % 99.79 %
EBIT Per Revenue TTM 11.8 % 29.3 % 11.8 % 14.38 % 33.18 %
Cash Flow To Debt Ratio TTM 17.88 % - 17.88 % 39.27 % 222.53 %
Receivables Turnover TTM 7.29 7.63 7.29 4.98 5.49
Payables Turnover TTM - 11.09 - 5.03 7.87
Inventory Turnover TTM 3.06 1.81 3.06 1.88 2.22
Fixed Asset Turnover TTM 312.12 % 186.61 % 312.12 % 197.54 % 724.52 %
Asset Turnover TTM 39.47 % 49.67 % 39.47 % 31.94 % 63.28 %
Operating Cash Flow Per Share TTM 11.97 8.3 11.97 4.16 12.86
Free Cash Flow Per Share TTM 9.32 6.37 9.32 3.23 12.06
Cash Per Share TTM 299.71 % 1376.56 % 299.71 % 284.33 % 944.79 %
Operating Cash Flow Sales Ratio TTM 15.71 % 30.8 % 15.71 % 20.57 % 35.82 %
Free Cash Flow Operating Cash Flow Ratio TTM 77.84 % 76.72 % 77.84 % 77.51 % 93.83 %
Cash Flow Coverage Ratios TTM 17.88 % - 17.88 % 39.27 % 222.53 %
Price To Free Cash Flows Ratio TTM 21.57 87.58 20.69 24.45 20.4
Price To Operating Cash Flows Ratio TTM 16.79 67.07 16.1 18.98 19.13
Price Cash Flow Ratio TTM 16.79 67.07 16.1 18.98 19.13
Income Statement (TTM)
BDXA MDLN ISRG BDX ALC RMD
Revenue $21.84B $8.35B $21.84B $9.91B $5.15B
Gross Profit $9.92B $5.63B $9.92B $5.51B $3.05B
Gross Profit Ratio 45.44% 67.46% 45.44% 55.61% 59.36%
EBITDA $4.96B $2.81B $4.96B $2.68B $1.91B
Net Income $1.68B $2.32B $1.68B $1.02B $1.4B
EPS Diluted 5.83 6.42 5.83 2.05 9.51
Balance Sheet (MRQ)
BDXA MDLN ISRG BDX ALC RMD
Long Term Debt $17.62B $0.11B $17.62B $4.97B $0.81B
Total Liabilities $29.94B $2.31B $29.94B $8.79B $2.21B
Total Equity $25.39B $16.53B $25.39B $21.55B $5.97B
Total Investments $0.01B $7.05B $0.01B $0.91B $0.09B
Total Debt $19.18B $0.15B $19.18B $5.14B $0.85B
Total Assets $55.33B $18.84B $55.33B $30.35B $8.17B
Cash Flow Statement (TTM)
BDXA MDLN ISRG BDX ALC RMD
Net Income $1.68B $2.34B $1.68B $1.02B $1.4B
Inventory $-0.41B $-0.83B $-0.41B $-0.05B $-0.08B
Dividends Paid $-1.2B $0B $-1.2B $-0.13B $-0.31B
Operating Cash Flow $3.43B $2.42B $3.43B $2.08B $1.75B
Capital Expenditure $-0.76B $-1.11B $-0.76B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 79.26
ANGO AngioDynamics, Inc. 13.15
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 123.63
ATRC AtriCure, Inc. 40.81
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.1
AZTA Azenta, Inc. 34.57
BAX Baxter International Inc. 19.29
BDX Becton, Dickinson and Company 195.36
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 16.88
BLFS BioLife Solutions, Inc. 25.01
COO The Cooper Companies, Inc. 82.48
DXR Daxor Corporation 12.665
EKSO Ekso Bionics Holdings, Inc. 4.73
FEMY Femasys Inc. 0.7664
Unlock